Commonwealth Equity Services, LLC Applied Genetic Technologies Corp Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022
SELL
$0.62 - $1.1 $372 - $660
-600 Reduced 4.74%
12,064 $9,000
Q1 2022

May 04, 2022
BUY
$1.07 - $2.71 $2,193 - $5,555
2,050 Added 19.31%
12,664 $13,000
Q4 2021

Jan 31, 2022
BUY
$1.87 - $2.91 $19,848 - $30,886
10,614 New
10,614 $20,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email